Abstract Context The European Association of Urology (EAU) Renal Cell Carcinoma (RCC)
Guideline Panel has prepared evidence-based guidelines and recommendations for the …

Renal cell carcinoma (RCC) is the most common type of urogenital cancer. It has a mortality
rate of 30-40% and is more commonly seen in men than women. In addition to gender, other …

Historically, kidney cancer was approached in a siloed single-speciality way, with urological
surgeons managing the localised stages of the disease and medical oncologists caring for …

Background There are no proven tumor biomarkers for the early diagnosis of clear cell renal
cell carcinoma (ccRCC) thus far. This study aimed to identify novel biomarkers of ccRCC …

Background The incidence of renal cell carcinoma (RCC) has increased in recent years.
Metastatic RCC is common and remains a major cause of mortality. A regulatory role for …

Objectives To review urinary protein biomarkers as potential non‐invasive, easily
obtainable, early diagnostic tools in renal cell carcinoma (RCC). Methods A PubMed …

Objectives Renal cell carcinoma (RCC) is often found incidentally in asymptomatic
individuals undergoing abdominal computed tomography (CT) examinations. The purpose …

Background Understanding pre-diagnostic test use could reveal diagnostic windows where
more timely evaluation for cancer may be indicated. Aim To examine pre-diagnostic patterns …

Renal cell carcinoma (RCC) represents the sixth most frequently diagnosed cancer in men
and is asymptomatic, being detected mostly incidentally. The apparition of symptoms …

Liquid biopsy—the determination of circulating cells, proteins, DNA or RNA from biofluids
through a “less invasive” approach—has emerged as a novel approach in all cancer entities …